Cost-Effectiveness Analysis of 68Ga-DOTATATE PET/MRI in Radiotherapy Planning in Patients with Intermediate-Risk Meningioma.

MLA

Rodriguez, J., et al. “Cost-Effectiveness Analysis of 68Ga-DOTATATE PET/MRI in Radiotherapy Planning in Patients with Intermediate-Risk Meningioma.” American Journal of Neuroradiology, vol. 44, no. 7, July 2023, pp. 783–91. EBSCOhost, https://doi.org/10.3174/ajnr.A7901.

APA

Rodriguez, J., Martinez, G., Mahase, S., Roytman, M., Haghdel, A., Kim, S., Madera, G., Magge, R., Pan, P., Ramakrishna, R., Schwartz, T. H., Pannullo, S. C., Osborne, J. R., Lin, E., Knisely, J. P. S., Sanelli, P. C., & Ivanidze, J. (2023). Cost-Effectiveness Analysis of 68Ga-DOTATATE PET/MRI in Radiotherapy Planning in Patients with Intermediate-Risk Meningioma. American Journal of Neuroradiology, 44(7), 783–791. https://doi.org/10.3174/ajnr.A7901

Chicago

Rodriguez, J., G. Martinez, S. Mahase, M. Roytman, A. Haghdel, S. Kim, G. Madera, et al. 2023. “Cost-Effectiveness Analysis of 68Ga-DOTATATE PET/MRI in Radiotherapy Planning in Patients with Intermediate-Risk Meningioma.” American Journal of Neuroradiology 44 (7): 783–91. doi:10.3174/ajnr.A7901.